Development of products and licences

In recent years and taking into account the globalization of markets and the growing trend of international expansion of drug development companies, Vegal Pharma, through its subsidiaries, has been carrying out an extensive program of new drug development since 1996, together with other new medicines from friendly laboratories that give up their rights, negotiate licensing and supply contracts that make their investments profitable and be present in all markets as suppliers, while in some cases the agreements allow free access to the importation of medicines that by different causes have a foreign origin.